Aktuellt
SENASTE
We see -10% organic growth in Q2, mainly an effect of quarterly volatility (H1 organic growth at +10%) with positive EBIT. In our view, SyntheticMR is on track to deliver on its 2023 guidance, implying >20% growth for the year, and we also see signs that margins will start to scale. We raise our sales estimates by 2% on FX and our new DCF-based fair value range is SEK 28-36 (27-35).
LÄS MER
